About the Company
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD).
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Adverum Biotechnologies, Inc.
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses ...
REDWOOD CITY, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for ...
Adverum Biotechnologies to Host Webcast to Review Clinical Data from ...
REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for ...
ADVM - Adverum Biotechnologies Inc News | Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM GlobeNewswire Apr 25, 2025 10:12am ...
Why Adverum Biotechnologies Stock Is Trading Higher
Adverum Biotechnologies, Inc. ADVM shares are trading higher Monday after the company announced that it has agreed to sell approximately 106.25 million shares in a $127.5 million private placement.
Bullish insiders at Adverum Biotechnologies, Inc. (NASDAQ:ADVM) loaded ...
Based on our data, Adverum Biotechnologies insiders have about 1.9% of the stock, worth approximately US$4.0m. We prefer to see high levels of insider ownership.
Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?
Adverum Biotechnologies Inc (NASDAQ: ADVM) revealed updated data from the OPTIC extension study of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) in patients with wet AMD ...
ADVM - Adverum Biotechnologies Inc Executives | Morningstar
Adverum Biotechnologies Inc ADVM Stock XNAS Rating as of Jun 5, 2025 Download PDF Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends ...
ADVM | Adverum Biotechnologies Inc. Profile | MarketWatch
Adverum Biotechnologies Inc. 100 Cardinal Way Redwood City, California 94063 Phone1 650 656-9323 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2025 Revenue$1M Net Income ...
Adverum Biotechnologies Inc. (ADVM) Stock Price Today - WSJ
View the latest Adverum Biotechnologies Inc. (ADVM) stock price, news, historical charts, analyst ratings and financial information from WSJ.
AVU0 | Adverum Biotechnologies Inc. Profile | MarketWatch
Adverum Biotechnologies Inc. 100 Cardinal Way Redwood City, California 94063 Phone1 650 656-9323 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2025 Revenue€1M Net ...
Adverum Biotechnologies Announces First Patient Randomized in ... - Nasdaq
--Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the first patient was randomized in the ...
Adverum Biotechnologies, Inc's (ADVM) CEO Laurent Fischer on Q4 2020 ...
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) Q4 2020 Earnings Conference Call March 1, 2021 4:30 PM ET Company Participants Myesha Lacy - Vice President, Investor Relations and Corporate ...
Similar Companies
Loading the latest forecasts...